DCW has announced a strategic investment programme of approximately ₹250 crore, marking the first phase of its next growth cycle. According to reports from Business Standard, the programme will focus on expanding Synthetic Iron Oxide Pigment (SIOP) capacity, introducing new value-added pigment products and strengthening captive power infrastructure at its Sahupuram manufacturing complex. The investment is being executed over a 2-3 year timeline to ensure comprehensive capacity expansion and infrastructure improvements, with the aim to capitalize on the growing global iron oxide pigments market and enhance profitability and market position.
The company plans to increase SIOP capacity by 50%, from approximately 30,000 tonnes per annum to 45,000 tonnes per annum, through a phased expansion. As reported by Business Standard, this expansion follows record SIOP sales volumes in FY26, with the business operating at effectively full capacity. The investment is expected to support further growth across domestic and international markets, with the enhanced capacity specifically designed to boost sales, competitiveness, and market presence in the iron oxide pigments sector. The expansion aims to capitalize on the growing global iron oxide pigments market, enhancing profitability and market position.
Alongside SIOP expansion, DCW will invest in improving the Sahupuram Power Plant as part of the comprehensive infrastructure development. According to latest reports, this power plant upgrade is designed to enhance energy efficiency and strengthen the cost competitiveness of both its Basic and Specialty Chemicals businesses. The power plant modernization forms a crucial component of the overall investment strategy to improve operational efficiency and reduce production costs across the company's manufacturing operations.
The expansion is supported by a sizeable global market and diversified end-use demand. According to industry estimates reported by Business Standard, the global iron oxide pigments market was approximately US$2.5-2.7 billion in 2025 and is projected to reach approximately US$3.9 billion by 2033, representing a 4.6% CAGR. Asia-Pacific is the largest regional market, accounting for approximately 41.5% of global revenue as of 2025.
The programme builds on DCW's multi-year shift towards higher-value chemicals. Over FY21 FY25, the Specialty Chemicals segment registered a 26% CAGR, while FY25 Specialty Chemicals EBITDA was 1.9x FY21 levels. As reported by Business Standard, Specialty Chemicals have become the major contributor to the Company's profitability, providing a more resilient earnings base against swings in Basic Chemicals. The company enters this investment cycle with a stronger balance sheet which turns Net Cash Positive at the exit of FY27.
